improving the speed and efficiency of patient care, automatic detection of abnormal cardiovascular activity in real time, and monitoring physiological variables in patients with coronary conditions.
HeartBeam (NASDAQ: BEAT), reported steady progress in its third quarter financial and operational results, advancing its cardiac care technology through key FDA 510(k) submissions and strategic ...
A Glasgow-based company is pleased to announce that three out of four cardiac centres in Scotland ... of vessels has become the standard of care. “However, the transition to EVH from ...